Explore our comprehensive coverage of drug development, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
October 2026 witnessed unprecedented FDA approvals of breakthrough therapies while NIH grant awards fell to six-year lows, creating a dangerous parado...
Read Full Story →Medical ResearchMedical research achieved unprecedented breakthroughs in 2025 with oral GLP-1 therapies, CRISPR gene...
Medical Research[The FDA's September 2026 approval of Zanvastro for Alexander disease and oral GLP-1 obesity pills, ...
Medical ResearchA landmark Stanford Medicine study published in Neuron reveals that tau protein drives Alzheimer's b...
